Virbac (Virbac) Total Liabilities : $566 Mil (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Virbac Total Liabilities?

Virbac's Total Liabilities for the quarter that ended in Jun. 2023 was $566 Mil.

Virbac's quarterly Total Liabilities declined from Jun. 2022 ($541.11 Mil) to Dec. 2022 ($523.86 Mil) but then increased from Dec. 2022 ($523.86 Mil) to Jun. 2023 ($566.31 Mil).

Virbac's annual Total Liabilities declined from Dec. 2020 ($552.66 Mil) to Dec. 2021 ($538.26 Mil) and declined from Dec. 2021 ($538.26 Mil) to Dec. 2022 ($523.86 Mil).

Virbac Total Liabilities Historical Data

The historical data trend for Virbac's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Total Liabilities Chart

Virbac Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

883.88

857.09

552.66

538.26

523.86

Virbac Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Liabilities	Get a 7-Day Free Trial															557.45	538.26	541.11	523.86	566.31

Virbac Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Virbac's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	413.756	+	(48.079	+	42.317
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	19.712)
	=	524

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	1412.618	-	888.753
	=	524

Virbac's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	408.745	+	(94.496	+	42.513
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	20.558)
	=	566

Total Liabilities	=	Total Assets (Q: Jun. 2023 )	-	Total Equity (Q: Jun. 2023 )
	=	1539.127	-	972.815
	=	566

Virbac Total Liabilities Related Terms

Thank you for viewing the detailed overview of Virbac's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac (Virbac) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

0NM7:UK VIRP:France V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.